Researchers evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies in a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with a high body mass index (BMI) (24.2-30.7 kg/m2) and abdominal visceral fat area (81.2-178.5 cm2) were randomly assigned to receive either fermented milk containing LG2055 (n=43) or fermented milk without LG2055 (n=44), and were asked to consume 200 g/day for 12 weeks. Abdominal fat area was determined by computed tomography.

In the group that received the probiotic in its milk, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6 percent. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4 percent; and waist, 1.8 percent. In the control group, by contrast, none of these parameters decreased significantly.

Image Galleries

Documentary

Modernizing The Chinese Supply Market
Explore how investments in science, technology and strategic partnerships are driving innovation and quality, and represent the best of the Chinese supply market in this 2-minute teaser. To watch the full 20-minute documentary underwritten by BGG, click here.